FDA.report

Application 203252

Type
ANDA
Sponsor
JUBILANT GENERICS

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001RIZATRIPTAN BENZOATERIZATRIPTAN BENZOATETABLET;ORALEQ 5MG BASENoNo
002RIZATRIPTAN BENZOATERIZATRIPTAN BENZOATETABLET;ORALEQ 10MG BASENoNo

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
50090-4619rizatriptan benzoaterizatriptan benzoateA-S Medication SolutionsANDACurrent
50090-4619rizatriptan benzoaterizatriptan benzoateA-S Medication SolutionsANDACurrent
59746-414rizatriptan benzoaterizatriptan benzoateJubilant Cadista Pharmaceuticals Inc.ANDACurrent
59746-414rizatriptan benzoaterizatriptan benzoateJubilant Cadista Pharmaceuticals Inc.ANDACurrent
59746-415rizatriptan benzoaterizatriptan benzoateJubilant Cadista Pharmaceuticals Inc.ANDACurrent
59746-415rizatriptan benzoaterizatriptan benzoateJubilant Cadista Pharmaceuticals Inc.ANDACurrent
71335-1346rizatriptan benzoaterizatriptan benzoateBryant Ranch PrepackANDACurrent
71335-1346rizatriptan benzoaterizatriptan benzoateBryant Ranch PrepackANDACurrent
72189-126RIZATRIPTAN BENZOATERIZATRIPTAN BENZOATEdirect rxANDACurrent
72189-126RIZATRIPTAN BENZOATERIZATRIPTAN BENZOATEdirect rxANDACurrent
72189-126RIZATRIPTAN BENZOATERIZATRIPTAN BENZOATEdirect rxANDACurrent